[Guidelines for Laevolac therapy against the endogenous factor in periodontal diseases].
D001419:Bacteria / Q000187:drug effects; D004187:Disaccharides / Q000627:therapeutic use*; D004573:Electrolytes / Q000378:metabolism; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007408:Intestinal Absorption; D007422:Intestines / Q000382:microbiology; D007778:Lactobacillus / Q000187:drug effects; D007792:Lactulose / Q000008:administration & dosage / Q000627:therapeutic use*; D010510:Periodontal Diseases / Q000188:drug therapy*; D012463:Saliva / Q000378:metabolism
D004187:Disaccharides; D004573:Electrolytes; D007792:Lactulose
Hinweise zur Durchführung der Laevolac-Therapie gegen den endogenen Faktor der Parodontopathien.